Membrane proteins are of critical importance to nearly every aspect of cell physiology, comprising quarter to one third of all proteins encoded by eubacterial, archaean, and eukaryotic organisms. Nevertheless, our understanding of their folding and structures is at a very primitive state when compared to that of water-soluble proteins. The M2 proton channel from influenza A virus provides an attractive system for understanding the folding and function of the viroporins. This growing class of helical viral ion channels is important for viral replication and packaging, and also provides good pharmaceutical targets. The M2 proton channel is essential to the survival of the virus, and is the target of the anti-influenza drugs, amantadine and rimantadine. The development of resistant strains of the virus has limited the effectiveness of these drugs, highlighting the importance of determining the structure of the protein-drug complex. The M2 proton channel is formed by the intermolecular association of four identical trans-membrane helices, and a synthetic peptide (M2tm) spanning only the trans-membrane helix of M2 forms amantadine-dependent channels in bilayers.
Our specific aims for the current period are to: 1. Determine the contributions of specific side-chains and the bilayer composition to the folding of M2tm and the full-length protein. 2. Using synthetic peptides and recombinant proteins we will examine the role of specific side-chains and structural features in the mechanism of channel gating, conductance, and inhibition by conducting ion channel measurements in vesicles and planar bilayers. In particular, we will evaluate the role of His37, which is essential for both gating and conductance, and its interactions with Trp41. 3. Use spectroscopic approaches (oriented CD, time-resolved fluorescence, NMR, EPR) to probe how changes in lipid composition, pH, and inhibitor binding affect the overall quaternary structure of the channel as well as the dynamics of side-chains involved in the function of the protein. 4. Determine the NMR structure of the full-length protein reconstituted in bicelles at pH 5, 8, and in the amantadine inhibited complex. 5. Determine the crystal structure of M2tm at pH 5, 8, and in the amantadine-inhibited complex.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM056423-09
Application #
6985050
Study Section
Biochemistry and Biophysics of Membranes Study Section (BBM)
Program Officer
Chin, Jean
Project Start
1997-08-01
Project End
2009-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
9
Fiscal Year
2005
Total Cost
$378,815
Indirect Cost
Name
University of Pennsylvania
Department
Biochemistry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hu, Yanmei; Musharrafieh, Rami; Ma, Chunlong et al. (2017) An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Antiviral Res 140:45-54
Li, Fang; Ma, Chunlong; DeGrado, William F et al. (2016) Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel. J Med Chem 59:1207-16
Huang, Shenstone; Green, Bryan; Thompson, Megan et al. (2015) C-terminal juxtamembrane region of full-length M2 protein forms a membrane surface associated amphipathic helix. Protein Sci 24:426-9
Gianti, Eleonora; Carnevale, Vincenzo; DeGrado, William F et al. (2015) Hydrogen-bonded water molecules in the M2 channel of the influenza A virus guide the binding preferences of ammonium-based inhibitors. J Phys Chem B 119:1173-83
Thomaston, Jessica L; Alfonso-Prieto, Mercedes; Woldeyes, Rahel A et al. (2015) High-resolution structures of the M2 channel from influenza A virus reveal dynamic pathways for proton stabilization and transduction. Proc Natl Acad Sci U S A 112:14260-5
Wu, Yibing; Canturk, Belgin; Jo, Hyunil et al. (2014) Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel. J Am Chem Soc 136:17987-95
Dong, Hao; Fiorin, Giacomo; DeGrado, William F et al. (2014) Proton release from the histidine-tetrad in the M2 channel of the influenza A virus. J Phys Chem B 118:12644-51
Rey-Carrizo, Matias; Barniol-Xicota, Marta; Ma, Chunlong et al. (2014) Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus. J Med Chem 57:5738-47
Polishchuk, Alexei L; Cristian, Lidia; Pinto, Lawrence H et al. (2014) Mechanistic insights from functional characterization of an unnatural His37 mutant of the influenza A/M2 protein. Biochim Biophys Acta 1838:1082-7
Williams, Jonathan K; Tietze, Daniel; Wang, Jun et al. (2013) Drug-induced conformational and dynamical changes of the S31N mutant of the influenza M2 proton channel investigated by solid-state NMR. J Am Chem Soc 135:9885-97

Showing the most recent 10 out of 50 publications